Similar articles for PMID: 20870149

Year	Number of Results
1989	1
1993	1
1994	2
1996	1
1997	2
1998	1
1999	5
2000	3
2001	6
2002	5
2003	7
2004	12
2005	5
2006	3
2007	7
2008	4
2009	7
2010	13
2011	18
2012	10
2013	4
2014	9
2015	1
2016	4
2017	3
2018	4
2019	2
2020	6
2021	6
2022	5
2023	1
2024	0

1

Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.

Hens M, Vaidyanathan G, Zhao XG, Bigner DD, Zalutsky MR. Hens M, et al. Nucl Med Biol. 2010 Oct;37(7):741-50. doi: 10.1016/j.nucmedbio.2010.04.020. Nucl Med Biol. 2010. PMID: 20870149 Free PMC article.

2

Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.

Hens M, Vaidyanathan G, Welsh P, Zalutsky MR. Hens M, et al. Nucl Med Biol. 2009 Feb;36(2):117-28. doi: 10.1016/j.nucmedbio.2008.11.001. Nucl Med Biol. 2009. PMID: 19217523 Free PMC article.

3

[¹⁷⁷Lu]-Labeled [(R)-2-amino-3-(4-isothiocyanatophenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A″-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII).

Chopra A. Chopra A. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348055 Free Books & Documents. Review.

4

[¹⁷⁷Lu]-Labeled α-(5-isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (MeO-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII).

Chopra A. Chopra A. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348051 Free Books & Documents. Review.

5

[¹⁷⁷Lu]-Labeled 2-(4-isothiocyanatobenzyl)-6-methyldiethylene-triaminepentaacetic acid (1B4M-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII).

Chopra A. Chopra A. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348053 Free Books & Documents. Review.

6

[¹⁷⁷Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII).

Chopra A. Chopra A. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348052 Free Books & Documents. Review.

7

[¹²⁵I]-Labeled monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII).

Chopra A. Chopra A. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 24 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348054 Free Books & Documents. Review.

8

Antitenascin antibody 81C6 armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands.

Yordanov AT, Hens M, Pegram C, Bigner DD, Zalutsky MR. Yordanov AT, et al. Nucl Med Biol. 2007 Feb;34(2):173-83. doi: 10.1016/j.nucmedbio.2006.11.003. Epub 2007 Jan 17. Nucl Med Biol. 2007. PMID: 17307125

9

In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.

Milenic DE, Garmestani K, Chappell LL, Dadachova E, Yordanov A, Ma D, Schlom J, Brechbiel MW. Milenic DE, et al. Nucl Med Biol. 2002 May;29(4):431-42. doi: 10.1016/s0969-8051(02)00294-9. Nucl Med Biol. 2002. PMID: 12031878

10

Preparation of ¹⁷⁷ Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators.

Pandey U, Kameswaran M, Gamre N, Dash A. Pandey U, et al. J Labelled Comp Radiopharm. 2019 Apr;62(4):158-165. doi: 10.1002/jlcr.3707. Epub 2019 Feb 17. J Labelled Comp Radiopharm. 2019. PMID: 30663095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

130 results

Results by year